COMPANY PROFILE

Newronika

Explore full profile

Restores brain and body functions with neural devices based on biosignal decoding

Cologno Monzese, ItalyFounded 2016Biotech & Life Sciences

Valuation $50–100M Last recorded · 2025

Revenue <$1M Latest reported FY

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Newronika

Developer of a neuro-modulation device designed to restore brain and body functioning. The company's therapeutic device uses the retro-activity system to record brain activity and modulate neuro-stimulation to collect, analyze and interpret bio-signals, enabling patients to receive the right stimulation at the right moment to perform normal daily activities and improve their quality of life.

MoreLess Source: Dealroom company data

At a glance

Status: Operational
Founded: 2016
Headquarters: Cologno Monzese, Italy
Employees: 25
Open positions: None listed
Dealroom signal: 69.8/100
Industry: Health
Sub-industry: BioTechnology, Medical Devices
Sector: Biotech & Life Sciences, Biotechnology, medical implants, Neurology, Neuromodulation and Neurostimulation, Degenerative Diseases, Spinout, EIC
Technology: Hardware, Deep Tech
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

10 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SERIES B✓Equity / VC	Feb 2025	$15M	$60M	Innogest Capital · Wille Finance · Indaco Venture Partners · TNBT Capital	↗
SUPPORT PROGRAM✓Other financing	Jan 2025	$0	—	EIT Health	—

Showing the latest 2 of 10 recorded eventsBook a demo for the full funding history →

Financials

Revenue, earnings and profit over time

Revenue, earnings and other financial measures where available. Years marked “E” are estimates.

Year	Revenue	Growth	EBITDA	Margin	Profit	Margin
2026
2025
2024
2023
2022
2021
2020		—

Company filings, research estimates and Dealroom dataBook a demo for the full financial model →

Growth signals

Newronika website traffic

Latest recorded traffic for Newronika is 1.3K monthly website visits, up 550% over the last three months. Newronika's team declined 7.4% over the past year.

Latest monthly visits1.3K 3-month web change+550% 1-year team growth-7.4%

Monthly website visitsJan 2016–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
LMLattice MedicalLattice Medical develops MATTISSE, a fully degradable 3D printed breast implant for natural, uncomplicated breast restoration	Loos, France	Operational	40	$61M	$189M
RNRestorative NeurotechnologiesProducing wearable medical device in order to enhance the strength of the rehabilitation for cognitive disease or enhance sport performance	Palermo, Italy	Operational
INInnitiusCervical Consistency + AI for improved accuracy in Birth Timing	Derio, Spain	Operational
LOLoci OrthopaedicsLoci Orthopaedics develops orthopaedic technologies to satisfy clinical demands in orthopaedics extremities	Galway, Ireland	Operational
NBNC BiomatrixDeveloping a patented injectable technology to improve the treatment of intervertebral disc degeneration	Eindhoven, Netherlands	Operational
LVLUMA VisionWe enable Cardiologists to save lives through exceptional decision-making accuracy	Dublin, Ireland	Operational
ININBRAIN NeuroelectronicsHigh-resolution graphene interfaces for precision neurology.	Barcelona, Spain	Operational
BIBiomimXDeveloping beating organs-on-chip platforms as in vitro pre-clinical models to improve the drug development process	Milan, Italy	Operational